CME Breakfast Symposium

Activity Chair: Jeffrey S. Weber, MD, PhD
7:00 am – 8:00 am
Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma
Supported by an educational grant from Bristol-Myers Squibb.

Welcome

8:00 am - 8:05 am
Opening Remarks

Immunotherapy Basics and Practical Considerations

Moderator: Sanjiv S. Agarwala, MD
8:05 am – 8:10 am
Pretest
8:11 am – 8:41 am
Basic Immunology for the Non-Immunologist
Young Kwang Chae, MD, MPH, MBA
8:42 am – 9:12 am
Practical Considerations for Immunotherapy: Response Assessment and Toxicity Management
Sanjiv S. Agarwala, MD
9:13 am – 9:43 am
Biomarkers and Immunotherapy
Nikhil I. Khushalani, MD
9:44 am – 10:00 am
Discussion and Posttest
10:00 am – 10:30 am
Refreshments and Networking in the Exhibit Hall

Melanoma

Moderator: Sanjiv S. Agarwala, MD
10:30 am – 10:35 am
Pretest
10:36 am – 10:56 am
Adjuvant Therapy for Melanoma: Where Do We Stand in 2018?
Sanjiv S. Agarwala, MD
10:57 am – 11:17 am
MSLT-2: Does this Change the Standard of Care for Sentinel Node Positive Disease?
Vernon K. Sondak, MD
11:18 am – 11:38 am
How I Treat Metastatic Melanoma in My Clinic: Immunotherapy, Targeted Therapy or Both?
Keith T. Flaherty, MD
11:39 am – 12:00 pm
New Immunotherapeutic Approaches in Advanced Melanoma: What Does the Future Hold?
Michael A. Postow, MD
12:01 pm – 12:23 pm
Discussion
12:24 pm – 12:30 pm
Posttest

Industry Expert Theater Lunch**

12:30 pm – 1:30 pm
Advancements in the Treatment of Stage IIIB/C and IV Melanoma
This educational event is sponsored by Amgen.
**Not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by HemOnc Today New York 2018 or its accredited provider.

Genitourinary Cancer

Moderator: Sanjiv S. Agarwala, MD
1:30 pm – 1:35 pm
Pretest
1:36 pm – 1:56 pm
Metastatic Renal Cell Carcinoma: So Many Choices, What’s a Clinician to Do?
Earle F. Burgess, MD
1:57 pm – 2:17 pm
Bladder Cancer: Is Immunotherapy the New Standard?
Joaquim Bellmunt, MD, PhD
2:18 pm – 2:38 pm
Prostate Cancer: What’s New?
Ravi A. Madan, MD
2:39 pm – 2:59 pm
Microsatellite Instable Tumors and Mutation Load: Clinical Implications for Therapy
Ramesh K. Ramanathan, MD
3:00 pm – 3:20 pm
Discussion
3:21 pm – 3:30 pm
Posttest
3:30 pm – 4:00 pm
Refreshments and Networking in the Exhibit Hall

Case Studies: Melanoma and Genitourinary Cancer

Moderator: Sanjiv S. Agarwala, MD
4:00 pm – 4:05 pm
Pretest
4:06 pm – 4:16 pm
Melanoma Case #1
Merrick I. Ross, MD
4:17 pm – 4:27 pm
Melanoma Case #2
Merrick I. Ross, MD
4:28 pm – 4:38 pm
Genitourinary Case #1
Ravi A. Madan, MD
4:39 pm – 4:49 pm
Genitourinary Case #2
Ravi A. Madan, MD
4:50 pm – 5:00 pm
Discussion and Posttest

Meet the Faculty Reception*

5:00 pm – 6:00 pm
Enjoy light refreshments and networking with faculty and colleagues.
*This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™.